RecruitingNCT06717594

PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to CRE

PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to Carbapenem-resistant Enterobacterales (CRE)

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

60 participants

Start Date

Dec 1, 2023

Study Type

OBSERVATIONAL

Conditions

Antimicrobial Resistance (AMR)Gram-negative Infections

Summary

A multicenter international prospective observational pharmacological study in adult patients (≥18 years) treated with ceftazidime/avibactam (CAZ/AVI) alone or with CAZ/AVI plus fosfomycin (FOS) for infection due to carbapenem-resistant Enterobacterales (CRE) (KPC and/or OXA-48).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with antimicrobial resistance (amr) and gram-negative infections. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(2)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bologna, Italy

Instituto de Biomedicina de Sevilla (IBiS), Hospital Virgen Macarena/CSIC/Universidad de Sevilla

Seville, Seville, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06717594

Related Trials

A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract Infections

NCT0682884822 locations

Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients

NCT073721311 location

The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)

NCT074914191 location

A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected Severe Gram-negative Bacterial Infections

NCT070630951 location

NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria

NCT050177661 location